JP2011511789A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511789A5
JP2011511789A5 JP2010545893A JP2010545893A JP2011511789A5 JP 2011511789 A5 JP2011511789 A5 JP 2011511789A5 JP 2010545893 A JP2010545893 A JP 2010545893A JP 2010545893 A JP2010545893 A JP 2010545893A JP 2011511789 A5 JP2011511789 A5 JP 2011511789A5
Authority
JP
Japan
Prior art keywords
composition
cis
retinyl
synthetic retinal
once
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010545893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011511789A (ja
JP6022746B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/000824 external-priority patent/WO2009102418A1/en
Publication of JP2011511789A publication Critical patent/JP2011511789A/ja
Publication of JP2011511789A5 publication Critical patent/JP2011511789A5/ja
Application granted granted Critical
Publication of JP6022746B2 publication Critical patent/JP6022746B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010545893A 2008-02-11 2009-02-10 加齢関連性網膜機能不全の治療及び予防方法 Expired - Fee Related JP6022746B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2762508P 2008-02-11 2008-02-11
US61/027,625 2008-02-11
PCT/US2009/000824 WO2009102418A1 (en) 2008-02-11 2009-02-10 Methods for the treatment and prevention of age-related retinal dysfunction

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2014157921A Division JP5934304B2 (ja) 2008-02-11 2014-08-01 加齢関連性網膜機能不全の治療及び予防方法
JP2016094767A Division JP6272943B2 (ja) 2008-02-11 2016-05-10 加齢関連性網膜機能不全の治療及び予防方法

Publications (3)

Publication Number Publication Date
JP2011511789A JP2011511789A (ja) 2011-04-14
JP2011511789A5 true JP2011511789A5 (cg-RX-API-DMAC7.html) 2012-04-05
JP6022746B2 JP6022746B2 (ja) 2016-11-09

Family

ID=40521846

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010545893A Expired - Fee Related JP6022746B2 (ja) 2008-02-11 2009-02-10 加齢関連性網膜機能不全の治療及び予防方法
JP2014157921A Active JP5934304B2 (ja) 2008-02-11 2014-08-01 加齢関連性網膜機能不全の治療及び予防方法
JP2016094767A Expired - Fee Related JP6272943B2 (ja) 2008-02-11 2016-05-10 加齢関連性網膜機能不全の治療及び予防方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014157921A Active JP5934304B2 (ja) 2008-02-11 2014-08-01 加齢関連性網膜機能不全の治療及び予防方法
JP2016094767A Expired - Fee Related JP6272943B2 (ja) 2008-02-11 2016-05-10 加齢関連性網膜機能不全の治療及び予防方法

Country Status (14)

Country Link
US (7) US8324270B2 (cg-RX-API-DMAC7.html)
EP (1) EP2252276B1 (cg-RX-API-DMAC7.html)
JP (3) JP6022746B2 (cg-RX-API-DMAC7.html)
KR (2) KR101810381B1 (cg-RX-API-DMAC7.html)
CN (1) CN101969938A (cg-RX-API-DMAC7.html)
AU (1) AU2009213138B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0908154A2 (cg-RX-API-DMAC7.html)
CA (2) CA3018374A1 (cg-RX-API-DMAC7.html)
IL (2) IL207220B (cg-RX-API-DMAC7.html)
MX (1) MX337656B (cg-RX-API-DMAC7.html)
NZ (3) NZ617701A (cg-RX-API-DMAC7.html)
RU (1) RU2565448C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009102418A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201005434B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060281821A1 (en) 2003-03-14 2006-12-14 Krzysztof Palczewski Retinoid replacements and opsin agonists and methods for the use thereof
AU2005257997B2 (en) 2004-06-18 2012-04-05 University Of Washington Retinal derivatives and methods for the use thereof for the treatment of visual disorders
AU2006249866B2 (en) 2005-05-26 2011-10-13 Aldeyra Therapeutics, Inc. Compositions and methods of treating retinal disease
US8324270B2 (en) * 2008-02-11 2012-12-04 University Of Washington Methods for the treatment and prevention of age-related retinal dysfunction
RU2546005C2 (ru) 2009-09-15 2015-04-10 Кью Эл Ти ИНК. Фармацевтические составы, содержащие 9-цис-ретиниловые сложные эфиры в липидном наполнителе
WO2011071995A2 (en) 2009-12-08 2011-06-16 Case Western Reserve University Compounds and methods of treating ocular disorders
CA2782015C (en) 2009-12-11 2020-08-25 Neuron Systems, Inc. Topical ophthalmic compositions and methods for the treatment of macular degeneration
SG10201507819VA (en) * 2010-04-19 2015-10-29 Quadra Logic Tech Inc Therapeutic Regimen And Methods For Treating Or Ameliorating Visual Disorders Associated With An Endogenous Retinoid Deficiency
US8846723B2 (en) 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
US8613940B2 (en) 2010-09-03 2013-12-24 Eastman Chemical Company Carbonate derivatives as skin care
US8329938B2 (en) * 2011-02-21 2012-12-11 Eastman Chemical Company Hydroxyalkanoic acid and hydroxyalkanoice acid oligomer esters of retinol
WO2013082149A1 (en) * 2011-11-28 2013-06-06 Case Western Reserve University Polysaccharide therapeutic conjugates
AU2013232697B2 (en) * 2012-03-01 2017-10-19 Eluminex Biosciences (Suzhou) Limited Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency
CN111135171B (zh) 2013-01-23 2023-09-08 奥尔德拉医疗公司 与毒性醛相关的疾病和治疗
US10471118B2 (en) 2014-05-30 2019-11-12 Case Western Reserve University Retinylamine derivitives for treatment of ocular disorders
US11129845B2 (en) 2014-06-18 2021-09-28 Case Western Reserve University Compositions and methods for the delivery of nucleic acids
US10925980B2 (en) 2014-08-04 2021-02-23 Case Western Reserve University Molecular probes and methods of use
US11407786B2 (en) 2015-06-18 2022-08-09 Case Western Reserve University Compositions and methods for the delivery of nucleic acids
CN118724806A (zh) 2015-08-21 2024-10-01 奥尔德拉医疗公司 氘化化合物和其用途
US12060318B2 (en) 2015-10-09 2024-08-13 Case Western Reserve University Compositions and methods for the delivery of nucleic acids
CN109152774A (zh) 2016-05-09 2019-01-04 奥尔德拉医疗公司 眼部炎性病症和疾病的组合治疗
WO2018170476A1 (en) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CN111356451A (zh) 2017-10-10 2020-06-30 奥尔德拉医疗公司 炎性病症的治疗
CN112714762A (zh) 2018-08-06 2021-04-27 奥尔德拉医疗公司 多晶型化合物及其用途
CN113784954A (zh) 2019-05-02 2021-12-10 奥尔德拉医疗公司 多晶型化合物和其用途
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
US12558336B2 (en) 2019-09-25 2026-02-24 The Board Of Trustees Of The Leland Stanford Junior University Metabolic rescue of retinal degeneration
WO2021231792A1 (en) 2020-05-13 2021-11-18 Aldeyra Therapeutics, Inc. Pharmaceutical formulations and uses thereof
EP4161502A4 (en) * 2020-06-09 2024-07-10 Eluminex Biosciences (Suzhou) Limited Methods of treating visual disorders using daily low dosing of a retinoid compound

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196076A (en) 1961-12-20 1965-07-20 Schering Corp Anti-depressant 10-(3-dimethylaminopropyl)-3-azaphenothiazine
US3196078A (en) * 1962-01-30 1965-07-20 Ortho Pharma Corp Process for combating retinits pigmentosa
US3517067A (en) 1964-02-11 1970-06-23 Eastman Kodak Co Syntheses of quaternary phosphonium salts
DE2300107C2 (de) 1973-01-03 1982-03-11 Basf Ag, 6700 Ludwigshafen Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen
DE2456959A1 (de) 1974-12-03 1976-06-16 Basf Ag 4-(e)- und 4-(z)-7-methyl-9-(2,6,6trimethyl-1-cyclohexen-1-yl)-nona-2,4,6,8tetraencarbonsaeure, ihre derivate und diese enthaltende zubereitungen
JPS61275266A (ja) 1985-05-28 1986-12-05 Taisho Pharmaceut Co Ltd レチノイド誘導体
US5310764A (en) 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene
JPH06340525A (ja) 1993-06-02 1994-12-13 Lion Corp 安定な低眼刺激性ビタミンa類可溶化点眼剤
EP0754046A1 (en) 1994-04-04 1997-01-22 FREEMAN, William R. Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
RU2106843C1 (ru) 1994-06-29 1998-03-20 Красноярская государственная медицинская академия Способ лечения близорукости
JPH08198746A (ja) 1995-01-18 1996-08-06 Lion Corp 可溶化点眼剤
US5837728A (en) 1995-01-27 1998-11-17 Molecular Design International 9-cis retinoic acid esters and amides and uses thereof
US5489611A (en) 1995-02-10 1996-02-06 Warner-Lambert Company Method for lowering plasma levels of lipoprotein (a)
US5620970A (en) 1995-06-05 1997-04-15 Alcon Laboratories, Inc. Topical ophthalmic carbonic anhydrase inhibitor formulations
US5716627A (en) 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
EP0908179A1 (en) 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US6391924B1 (en) * 1997-12-10 2002-05-21 Hampar Karageozian Taurine derivatives useable in the treatment of ophthalmic disorders
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
US6372463B1 (en) 1999-05-06 2002-04-16 The President & Fellows Of Harvard College Mutations in nucleic acid molecules encoding 11-CIS retinol dehydrogenase, the mutated proteins, and uses thereof
AU4993100A (en) 1999-05-07 2000-11-21 Chemlink Laboratories, Llc Window cleaner tablet
US6300328B1 (en) 1999-08-06 2001-10-09 Alcon Universal Ltd. Selective inhibitors of adenosine monophosphate deaminase for the treatment of optic nerve and retinal damage
US20020028849A1 (en) 2000-04-18 2002-03-07 Godkin James D. Use of retinol in assisted-reproduction protocols
US6696069B2 (en) 2000-06-30 2004-02-24 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin care cosmetic compositions containing phosphates and/or sulfates of branched alcohols and/or ethoxylates thereof
EP1261623B1 (en) 2001-01-11 2009-11-04 Chebigen Inc. New retinol derivatives, the method of preparations and the uses thereof
AU2002240141A1 (en) 2001-01-26 2002-08-06 Steven Baranowitz Systemic formulations containing beta-carotene and derivatives thereof
GB0103998D0 (en) 2001-02-19 2001-04-04 King S College London Method
CA2442670A1 (en) 2001-04-13 2002-10-24 The Trustees Of The University Of Pennsylvania Method of treating or retarding the development of blindness
CA2474154A1 (en) 2002-01-18 2003-07-24 Tatton Technologies, Llc. Methods for treating eye disorders
US20030215413A1 (en) 2002-03-22 2003-11-20 L'oreal Compositions containing stabilized retinoid
US20040097587A1 (en) 2002-03-27 2004-05-20 Arbiser Jack L Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
CN1741811A (zh) 2002-03-29 2006-03-01 马克西姆医药公司 Rom产生与释放抑制剂治疗和预防眼内损伤的用途
US20060281821A1 (en) 2003-03-14 2006-12-14 Krzysztof Palczewski Retinoid replacements and opsin agonists and methods for the use thereof
WO2005079774A2 (en) 2004-02-17 2005-09-01 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
JP2007525496A (ja) * 2004-02-17 2007-09-06 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 黄班変性症を含む眼科疾患の管理
US7566808B2 (en) 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
CN1964706A (zh) 2004-03-17 2007-05-16 拉斯·M·拉森 通过抑制视觉周期预防视网膜病
AU2005257997B2 (en) 2004-06-18 2012-04-05 University Of Washington Retinal derivatives and methods for the use thereof for the treatment of visual disorders
KR100862930B1 (ko) 2004-06-23 2008-10-13 시리온 테라퓨틱스, 인크. 레티닐 유도체를 사용하여 안 증상을 치료하기 위한 방법및 조성물
AU2005287343A1 (en) 2004-08-18 2006-03-30 Sirion Therapeutics, Inc. Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
WO2006039551A2 (en) 2004-09-30 2006-04-13 The Regents Of The University Of California Local administration of retinoids to treat deficiencies in dark adaptation
JP5149388B2 (ja) 2007-09-12 2013-02-20 ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 黄斑変性症を処置するための組成物及び方法
US8324270B2 (en) * 2008-02-11 2012-12-04 University Of Washington Methods for the treatment and prevention of age-related retinal dysfunction

Similar Documents

Publication Publication Date Title
JP2018514534A5 (cg-RX-API-DMAC7.html)
US20080089861A1 (en) Combination therapy for treatment of demyelinating conditions
NZ600498A (en) Methods for the treatment and prevention of age-related retinal dysfunction
JP2012520866A5 (cg-RX-API-DMAC7.html)
RU2004123637A (ru) Фармацевтические лекарственные формы контролируемого высвобождения ингибитора транспортного белка холестерилового
JP2008189635A (ja) 疼痛疾患治療剤
CA2549801A1 (en) Use of treprostinil to improve kidney functions
AU2012250877B2 (en) Composition and method for treatment of diabetes
JP2012530723A5 (cg-RX-API-DMAC7.html)
US10363235B2 (en) Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same
ITBO20110012A1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
US20100004203A1 (en) Medicament for preventive and/or therapeutic treatment of bowel disease
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
JP2012502047A5 (cg-RX-API-DMAC7.html)
EP2185146A1 (en) Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid
CN110314233B (zh) 包含柠檬苦素类化合物和dpp-4抑制剂的组合产品
WO2019029319A1 (zh) 包含柠檬苦素类化合物和双胍类化合物的组合产品
CN103458911A (zh) 肽组合物和用于治疗患者的方法
WO2021027582A1 (zh) 包含柠檬苦素类化合物和噻唑烷二酮类药物的组合产品
EP2293790A2 (fr) Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition pharmaceutique la contenant et son utilisation dans le traitement des troubles cognitifs
EA021395B1 (ru) Комбинация инсулина с триазиновыми производными и их применение для лечения диабета
WO2016138103A1 (en) Treatments for alzheimer's related diseases and disorders
WO2021027576A1 (zh) 包含柠檬苦素类化合物和sglt-2抑制剂的组合产品
WO2021027577A1 (zh) 包含柠檬苦素类化合物和α-糖苷酶抑制剂的组合产品
JP2013527844A5 (cg-RX-API-DMAC7.html)